MA
THRN

MYDA Advisors’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

MYDA Advisors’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-133,144
Closed -$615K – 189
2023
Q1 		$615K Sell
133,144
-16,856
-11% -$74.2K 0.26% 67
2022
Q4 		$545K Buy
+150,000
New +$665K 0.39% 55
2022
Q3 		– Sell
-69,000
Closed -$334K – 239
2022
Q2 		$334K Sell
69,000
-56,000
-45% -$340K 0.14% 139
2022
Q1 		$795K Buy
125,000
+23,095
+23% +$124K 0.33% 96
2021
Q4 		$633K Sell
101,905
-25,095
-20% -$196K 0.2% 143
2021
Q3 		$1.1M Buy
+127,000
New +$1.04M 0.4% 85

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return